The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First phase 3 results from CARTITUDE-4: Cilta-cel versus standard of care (PVd or DPd) in lenalidomide-refractory multiple myeloma.
 
Binod Dhakal
Honoraria - Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Amgen; Arcellx; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Natera; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen Oncology
Research Funding - Amgen (Inst); Arcellx (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Kwee Yong
Honoraria - Amgen; Janssen-Cilag; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Janssen-Cilag
Speakers' Bureau - Amgen; Sanofi; Takeda
Research Funding - Amgen; Autolus; Janssen-Cilag; Sanofi; Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Simon J. Harrison
Honoraria - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Haemalogix; Janssen Cilag; Novartis; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Haemalogix; Janssen Cilag; Novartis; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen Cilag; Novartis; Roche/Genentech; Takeda; TERUMO
Research Funding - Haemalogix (Inst); Janssen Cilag (Inst)
Expert Testimony - EUSA Pharma; TERUMO (Inst)
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Rakesh Popat
Honoraria - Abbvie; Celgene; GlaxoSmithKline; Janssen; Sanofi
Consulting or Advisory Role - BeiGene; Celgene; GlaxoSmithKline; Janssen; Roche
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
 
Nikoletta Lendvai
Employment - Janssen
 
Carolina Lonardi
Employment - Janssen
Leadership - Janssen
Stock and Other Ownership Interests - Johnson & Johnson; Johnson & Johnson (I)
Travel, Accommodations, Expenses - Janssen
 
Ana Slaughter
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Jordan Mark Schecter
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Katherine Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Enrique Zudaire
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patents pending with Janssen
Travel, Accommodations, Expenses - Janssen Research & Development
 
Ying Chen
Employment - Janssen Research & Development
 
Jane Gilbert
Employment - Janssen Research & Development
 
Lida Bubuteishvili-Pacaud
Employment - Legend Biotech
Leadership - Legend Biotech
Stock and Other Ownership Interests - Gilead Sciences (I); Legend Biotech
 
Nitin Patel
Employment - Legend Biotech
 
Jesús San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Haemalogix (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sanofi (Inst); Secura Bio (Inst); Takeda (Inst)
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda